Keyphrases
Tumor Growth
100%
Protein Kinase
100%
Apoptosis Induction
100%
Anticancer Drugs
100%
Murine Model
100%
Lung Carcinoma Cells
100%
Inhibit Tumor
100%
Lung Carcinoma
100%
Drug Discovery
50%
Nanoparticles
50%
SCID Mice
50%
Antitumor Activity
50%
Cisplatin
50%
Apoptotic Pathway
50%
Mechanism of Action
50%
Cancer Cells
50%
Histological Analysis
50%
Oral Administration
50%
Human Fibroblasts
50%
Apoptosis
50%
In Vitro Activity
50%
Cell Viability Assay
50%
Intraperitoneal Injection
50%
Anti-apoptotic Proteins
50%
DNA Fragmentation
50%
Human Umbilical Vein Endothelial Cells (HUVECs)
50%
Isoborneol
50%
In Vivo Growth
50%
In Vivo Tumor Growth
50%
NCI-60
50%
In Silico Modeling
50%
Quantitative Structure-activity Relationship
50%
A549 Cancer Cell Line
50%
Molecular Topology
50%
Blood Analysis
50%
Cancer Cell Line Panel
50%
Metastatic Spread
50%
MCF-7 Cancer Cell Line
50%
Signaling Kinases
50%
Severe Adverse Events
50%
Animal Survival
50%
Medicine and Dentistry
Tumor Progression
100%
Programmed Cell Death
100%
Lung Carcinoma
100%
Blinatumomab
100%
Carcinoma Cell
22%
Cancer Cell Line
22%
Protein Kinase C
22%
In Vitro
11%
Cancer Cell
11%
Anticarcinogen
11%
Oral Drug Administration
11%
Adverse Event
11%
In Silico
11%
DNA Fragmentation
11%
Antineoplastic Activity
11%
Cell Viability Assay
11%
MCF-7
11%
Intraperitoneal Drug Administration
11%
Structure-Activity Relationship
11%
Isoborneol
11%
Cisplatin
11%
SCID Mouse
11%
Nanoparticle
11%
Fibroblast
11%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Growth
100%
Lung Carcinoma
100%
Blinatumomab
100%
Malignant Neoplasm
33%
Protein Kinase C
22%
Drug Discovery
11%
Cisplatin
11%
Viability Assay
11%
Quantitative Structure-Activity Relationship
11%
NOD SCID Mouse
11%
Cell Viability
11%
Nanoparticle
11%
Anticarcinogen
11%
Adverse Event
11%
Intraperitoneal Injection
11%
Isoborneol
11%
Neoplasm
11%
Quantitative Structure Activity Relation
11%